XDx's AlloMap May Reduce Post-Transplant Biopsies - NYTimes.com
Links shared publicly online about this topic.
- 1,222total visits
XDx's AlloMap May Reduce Post-Transplant Biopsies - NYTimes.com
A study found that a test that analyzes genetic activity may help avoid invasive approaches to detect rejection of transplanted hearts.
View full resource at nytimes.com
Tags: Heart, Genetic, Organ Transplantation, Heart Transplant, Lab Test, Genes, Transplantation
Most Recently Shared on April 22, 2010 at 4:34 pm By:
Blood test for rejection gene markers may preclude need for cardiac biopsy in heart transplant patients http://nyti.ms/aIUsw7
Advertisement
